Clinical Trial Update: First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing first-line radiofrequency ablation to antiarrhythmic drugs for persistent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of Pennsylvania | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED